Tissue factor and tissue factor pathway inhibitor in haemodialysis patients.
Yamashita K, Harada S (Harada Hospital), Wakabayashi K (SRL Inc.),Yorioka N Yamakido M (Second Department of Internal Medicine, Hiroshima Univ. of Medicine, Japan)
Development and operation of a monitoring system for haemodialysis.
Usui K, Honmaru T (Harada Hospital), Hagiwara Y (Nikkiso Inc. Tokyo),Yorioka N Yamakido M (Second Department of Internal Medicine, Hiroshima Univ. ofMedicine, Japan)
Comparison of mortality between HD and CAPD patients.
Shigemoto K (Harada Hspt), Ishida H (Matsue Red Cross Hspt), Hara Y(Yamaguchi Pref Central Hspt) Nakamura Y (National Hiroshima Hspt), Fujiowara K(Kure Kyosai Hspt)
